Sanofi India's stock tanked 10.22 per cent to settle at Rs 2,900. In intra-day trade, the scrip plunged 10.99 per cent to Rs 2,875.

The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.